These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 7233133)
41. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis. McDougall NI; Johnston BT; Collins JS; McFarland RJ; Love AH Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1161-7. PubMed ID: 9471021 [TBL] [Abstract][Full Text] [Related]
42. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus. Smythe A; Bird NC; Troy GP; Globe J; Johnson AG Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019 [TBL] [Abstract][Full Text] [Related]
43. Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state. Behar J; Biancani P Gastroenterology; 1976 Mar; 70(3):331-5. PubMed ID: 765184 [TBL] [Abstract][Full Text] [Related]
44. [Functional disorders of the esophagus. Diagnosis and therapy]. Rösch W Fortschr Med; 1979 Jan; 97(4):129-33. PubMed ID: 422103 [TBL] [Abstract][Full Text] [Related]
46. Current concepts in the pathogenesis and treatment of reflux esophagitis. Frazier JL; Fendler KJ Clin Pharm; 1983; 2(6):546-57. PubMed ID: 6360495 [TBL] [Abstract][Full Text] [Related]
47. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants. Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433 [TBL] [Abstract][Full Text] [Related]
49. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease? Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223 [TBL] [Abstract][Full Text] [Related]
50. Total acid suppression and its effect on Barrett's esophagus. Castell DO Am J Manag Care; 2000 Oct; 6(16 Suppl):S895-8. PubMed ID: 11184662 [TBL] [Abstract][Full Text] [Related]
51. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both? Tack J; Koek G; Demedts I; Sifrim D; Janssens J Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713 [TBL] [Abstract][Full Text] [Related]
52. Reflux disease and Barrett's esophagus. Louis H Endoscopy; 2007 Nov; 39(11):969-73. PubMed ID: 17926239 [No Abstract] [Full Text] [Related]
53. Gastroesophageal reflux. Wu WC; Castell DO Compr Ther; 1983 Nov; 9(11):57-63. PubMed ID: 6357615 [No Abstract] [Full Text] [Related]
54. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Richter JE; Castell DO Ann Intern Med; 1982 Jul; 97(1):93-103. PubMed ID: 6124198 [TBL] [Abstract][Full Text] [Related]
55. Acid reflux and gastro-oesophageal reflux disease. Watson AR; Bowling TE Br J Community Nurs; 2004 Aug; 9(8):326-30. PubMed ID: 15365470 [TBL] [Abstract][Full Text] [Related]
56. Diagnosis and treatment of gastroesophageal reflux, or reflux revisited. O'Connor KW Compr Ther; 1985 Dec; 11(12):6-13. PubMed ID: 2866868 [No Abstract] [Full Text] [Related]
57. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. McCallum RW; Ippoliti AF; Cooney C; Sturdevant RA N Engl J Med; 1977 Feb; 296(7):354-7. PubMed ID: 319356 [TBL] [Abstract][Full Text] [Related]
58. [Primperan and gastroesophageal reflux. Review of the literature]. Albot G Ann Gastroenterol Hepatol (Paris); 1985 May; 21(2 Pt 2):17-20. PubMed ID: 3898989 [TBL] [Abstract][Full Text] [Related]